Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00354458
Status:
COMPLETED
Last Update Posted:
2009-10-09
First Post:
2006-07-18
Brief Title:
PROTECT-2 A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function
Sponsor:
NovaCardia Inc a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization:
NovaCardia Inc a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization Data
Organization:
NovaCardia Inc a subsidiary of Merck Co Inc Rahway New Jersey USA
Class:
INDUSTRY
Study ID:
CKI-302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NovaCardia Inc a subsidiary of Merck Co Inc Rahway New Jersey USA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Executive Vice President Clinical and Quantitative Sciences
Old Organization:
Merck Co Inc
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |